BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: M Qunies A, A Emmitte K. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies. Pharm Pat Anal 2022. [PMID: 35369761 DOI: 10.4155/ppa-2022-0002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gribkoff VK, Winquist RJ. Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention. Biochem Pharmacol 2023;208:115413. [PMID: 36646291 DOI: 10.1016/j.bcp.2023.115413] [Reference Citation Analysis]
2 Qunies AM, Mishra NM, Spitznagel BD, Du Y, Acuña VS, David Weaver C, Emmitte KA. Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels. Bioorganic & Medicinal Chemistry Letters 2022. [DOI: 10.1016/j.bmcl.2022.129013] [Reference Citation Analysis]